Nls Pharmaceutics Ltd (NLSP) has released an update.
NLS Pharmaceutics Ltd. has issued Common Share Purchase Warrants that will allow holders to purchase shares at a fixed price, starting from March 22, 2024, until March 22, 2029. These securities have not been registered with the SEC, meaning they can only be sold following specific exemptions or state securities laws. The announcement includes details on the exercise of the warrants, pricing, and the mechanics of how shares will be issued upon exercise.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
